Nu-Med Plus (NUMD) Equity Average (2013 - 2025)
Nu-Med Plus recorded quarterly Equity Average of -$264969.0 in Q4 2025, down 4.86% quarter-over-quarter from -$252677.0 in Q3 2025, and down 26.28% year-over-year from -$359449.9 in Q4 2024.
Nu-Med Plus' Equity Average history runs 13 years deep, the most recent figure standing at -$264969.0 for Q4 2025.
- In Q4 2025, Equity Average fell 26.28% year-over-year to -$264969.0; the TTM figure through Dec 2025 stood at -$264969.0 (down 26.28% YoY), while the FY2025 annual figure was -$243187.0, down 34.41% from the prior year.
- Equity Average came in at -$264969.0 for Q4 2025 at Nu-Med Plus, down from -$252677.0 in the prior quarter.
- In the past five years, Equity Average ranged from a high of $329329.0 in Q1 2021 to a low of -$264969.0 in Q4 2025.
- A 5-year average of -$134202.6 and a median of -$163631.2 in 2022 frame the typical range for Equity Average.
- Across the five-year window, Equity Average jumped 327.71% in 2021 and plunged 621.68% in 2022, its largest moves.
- Nu-Med Plus' Equity Average stood at -$101187.5 in 2021, then tumbled by 64.62% to -$166578.0 in 2022, then increased by 16.34% to -$139353.0 in 2023, then slumped by 50.57% to -$209818.5 in 2024, then slipped by 26.28% to -$264969.0 in 2025.
- According to Business Quant data, Equity Average over the past three periods registered -$264969.0, -$252677.0, and -$240861.5 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Nu-Med Plus | - | - | - | -264,969.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -264,969.00 |
| Sep 30, 2025 | -252,677.00 |
| Jun 30, 2025 | -240,861.50 |
| Mar 31, 2025 | -225,062.50 |
| Dec 31, 2024 | -209,818.50 |
| Sep 30, 2024 | -195,202.50 |
| Jun 30, 2024 | -177,220.50 |
| Mar 31, 2024 | -157,664.00 |
| Dec 31, 2023 | -139,353.00 |
| Sep 30, 2023 | -123,752.00 |
| Jun 30, 2023 | -103,389.00 |
| Mar 31, 2023 | -77,127.00 |
| Dec 31, 2022 | -166,578.00 |
| Sep 30, 2022 | -258,606.00 |
| Jun 30, 2022 | -218,046.00 |
| Mar 31, 2022 | -160,684.50 |
| Dec 31, 2021 | -101,187.50 |
| Sep 30, 2021 | -35,834.00 |
| Jun 30, 2021 | 94,652.00 |
| Mar 31, 2021 | 329,329.00 |
| Dec 31, 2020 | 344,689.00 |
| Sep 30, 2020 | 316,631.00 |
| Jun 30, 2020 | 22,130.00 |
| Mar 31, 2020 | -368,879.50 |
| Dec 31, 2019 | -336,922.00 |
| Sep 30, 2019 | -305,333.00 |
| Jun 30, 2019 | -265,961.00 |
| Mar 31, 2019 | -88,070.50 |
| Dec 31, 2018 | 121,505.50 |
| Sep 30, 2018 | 84,827.50 |
| Jun 30, 2018 | -22,926.50 |
| Mar 31, 2018 | 23,609.00 |
| Dec 31, 2017 | 56,608.50 |
| Sep 30, 2017 | -26,011.00 |
| Jun 30, 2017 | -66,823.50 |
| Mar 31, 2017 | -2.24 Mn |
| Dec 31, 2016 | -2.29 Mn |
| Sep 30, 2016 | 220,545.50 |
| Jun 30, 2016 | 161,956.50 |
| Mar 31, 2016 | -7.74 Mn |
| Dec 31, 2015 | -7.72 Mn |
| Sep 30, 2015 | -200,466.50 |
| Jun 30, 2015 | -180,439.00 |
| Mar 31, 2015 | -3.64 Mn |
| Dec 31, 2014 | -3.58 Mn |
| Sep 30, 2014 | 115,330.50 |
| Jun 30, 2014 | 264,243.00 |
| Mar 31, 2014 | 59,860.00 |
| Dec 31, 2013 | -135,017.00 |
| Sep 30, 2013 | -155,296.00 |
| Jun 30, 2013 | -146,819.50 |
| Mar 31, 2013 | -87,413.00 |